NDC 0986-0813 - Surolan
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0986-0813
- Package NDCs from labels
- 0986-0813-15, 0986-0813-30
- Manufacturer
- ELANCO ANIMAL HEALTH CO | Olon SpA | Lusomedicamenta Sociedade Tecnica Farmaceutica, S.A., | EuroAPI France | Xellia Pharmaceuticals ApS
- Effective date
- 2022-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Surolan™ | ELANCO ANIMAL HEALTH CO | Olon SpA | Lusomedicamenta Sociedade Tecnica Farmaceutica, S.A., | EuroAPI France | Xellia Pharmaceuticals ApS | 2022-09-30 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| foster and thrive miconazole | MICONAZOLE NITRATE | Strategic Sourcing Services LLC | 09c4f6c9-ba51-47f4-95b4-d236fa45778b | 2023-10-25 | Warnings | VW4H1CYW1K |
| GENUINE FIRST AID Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 23abfe12-5b50-4b49-878e-4fcdb6c341fd | 2023-10-19 | Warnings | 19371312D4 |
| EVERLIT CARE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | f4921508-c32f-426f-a2f0-16c3acbd4713 | 2023-10-14 | Warnings | 19371312D4 |
| Miconazole 7 | MICONAZOLE NITRATE | Kroger Company | 9fc3df65-c441-44ab-aaac-f63b565ca2f5 | 2023-09-13 | Warnings | VW4H1CYW1K |
| Equaline Miconazole 7 | MICONAZOLE NITRATE | United Natural Foods, Inc. dba UNFI | 7ebd51d9-8578-48c8-804a-e80fbe514fa1 | 2023-08-02 | Warnings | VW4H1CYW1K |
| MAXITROL | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Novartis Pharmaceuticals Corporation | 22c6d2db-85af-4a3b-a014-80d901a86717 | 2023-06-27 | Warnings, Adverse reactions | 19371312D4 |
| Bactine Max Antibiotic and Lidocaine Max Pain Relief | LIDOCAINE | WellSpring Pharmaceutical Corporation | 71300df9-6113-4f25-93ca-28ad7e7f79de | 2023-06-08 | Warnings | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Bausch & Lomb Incorporated | 4456d10b-9995-4430-b692-a8859ea36deb | 2023-06-01 | Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | Proficient Rx LP | 21c9b34c-af88-4c9e-9b6c-32d78d34ba7e | 2023-05-01 | Warnings, Adverse reactions | 19371312D4 |
| Prednisolone Acetate | PREDNISOLONE ACETATE | A-S Medication Solutions | b1d30a4f-4941-45a5-bd24-fea07f1bfc87 | 2023-04-30 | Warnings, Adverse reactions | 8B2807733D |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | A-S Medication Solutions | c895676f-446a-4a93-a3d2-addcce96b108 | 2023-01-23 | Warnings, Adverse reactions | 19371312D4 |
| Miconazole 7 | MICONAZOLE NITRATE | H2-Pharma, LLC | 4bf1a555-a24f-4807-ac13-db19c55cf280 | 2023-01-13 | Warnings | VW4H1CYW1K |
| Miconazole 7 | MICONAZOLE NITRATE | H2-Pharma, LLC | 67dc7d38-a663-48d5-9abf-b3bd8dc0eddf | 2023-01-13 | Warnings | VW4H1CYW1K |
| Polymyxin B | POLYMYXIN B SULFATE | Fresenius Kabi USA, LLC | 72dd6de6-31d6-4a8f-881b-91af91ed9314 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | Proficient Rx LP | 548089f3-29d8-4ba8-af21-9e04356ac29c | 2022-10-01 | Warnings, Adverse reactions | 19371312D4 |
| Miconazole 7 | MICONAZOLE NITRATE | QUALITY CHOICE (Chain Drug Marketing Association) | 68667d2e-d4d0-46e7-9d84-0f23fdac1cf7 | 2022-09-30 | Warnings | VW4H1CYW1K |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | f5ef71ae-fca9-4a57-ae88-f2b2d195a179 | 2022-08-01 | Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 98042cef-2839-49d6-a7bd-a1d29c74430b | 2022-05-02 | Warnings, Adverse reactions | 19371312D4 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Proficient Rx LP | 601cab21-c211-4c34-be7b-f4fdd97a921a | 2022-05-02 | Warnings, Adverse reactions | 19371312D4 |
| Polymyxin B | POLYMYXIN B SULFATE | Hikma Pharmaceuticals USA Inc. | 18daf0d1-b6f5-46f4-ab2f-01a594f3959c | 2022-04-28 | Boxed warning, Warnings, Adverse reactions | 19371312D4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.